Novo Nordisk | NVO - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
ANI Pharmaceuticals USD 597.21M 34.91M 2026-06
Aurora Cannabis CAD 511.83M 24.53M 2026-03
Bausch Health Companies USD -802M 1.26B 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Canopy Growth CAD 697.59M 60.58M 2026-03
Corcept Therapeutics USD 705.78M 67.79M 2026-06
Drreddys Laboratories INR 380.46B 376.31B 2026-03
Eli Lilly USD 33.88B 2.68B 2026-06
GlaxoSmithKline GBP 17.64B 223M 2026-06
Merck USD 41.93B 3.94B 2026-06
Nektar Therapeutics USD 576.22M 486.38M 2026-03
Novartis USD 41.95B 3.02B 2026-06
Novo Nordisk DKK 221.28B 18.21B 2026-06
Novo Nordisk DKK 33.81B 169.25B 2026-06
Pacira USD 671.98M 18.08M 2026-06
Perrigo USD 2.52B 17M 2026-06
Phibro Animal Health USD 385.48M 23.65M 2026-06
Prestige Brands USD 1.92B 29.2M 2026-06
Sanofi EUR 69.57B 3.24B 2026-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
Zoetis USD 3.15B 85M 2026-06